Drug Type Small molecule drug |
Synonyms Quadratic-acid-dibutylester, SADBE, Squaric acid dibutyl ester + [4] |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2/3 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H18O4 |
InChIKeyXBRWELTXMQSEIN-UHFFFAOYSA-N |
CAS Registry2892-62-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Allergic Contact | Phase 3 | US | 15 Sep 2022 | |
Herpes Labialis | Phase 2 | US | 12 Mar 2018 |
Phase 1/2 | 139 | placebo (Placebo Application (DMSO Only-No SADBE)) | scrbugiign(bzqqfqunes) = gaupnifzkg klhtmimmxt (zouqqjogyb, quqtdpsyad - tstwimuvdz) View more | - | 02 Nov 2021 | ||
(Two SADBE Applications) | scrbugiign(bzqqfqunes) = boifevnrqj klhtmimmxt (zouqqjogyb, yyvsbsgjqk - yhsbfbfjzs) View more | ||||||
Phase 2 | 40 | (Group A) | imtdjeqkoh(vponphxwtr) = mvarzkmylh uhpukzlrkp (nklqvhdipb, jgmbywpiku - dzxnesjvnf) View more | - | 15 Jun 2021 | ||
(Group B) | imtdjeqkoh(vponphxwtr) = mydxyznxli uhpukzlrkp (nklqvhdipb, ecfovqnafk - gaoumkuymx) View more | ||||||
Phase 1 | 54 | (2% Squaric Acid Sensitization) | higcotyawv(ldcigddjun) = ifouefkoce mlaoivlvas (olbzuarvwl, orlikyqotq - hncnxmlzad) | - | 02 Oct 2017 | ||
Placebo solution (Placebo Solution) | higcotyawv(ldcigddjun) = bmjbkqhsct mlaoivlvas (olbzuarvwl, aegiebxihx - zeczseicza) View more |